Interprotein Corporation

http://www.interprotein.com/

 

Interprotein is a biopharmaceutical company engages in discovering and developing of small molecule inhibitors for oral administration based on the deNovo molecular design method called "INTENDD" targeting Protein-Protein Interactions where the existing antibody therapeutics have proved the extent of market potential and the mechanism of effectiveness.

Pipeline:　 1. Il-6 inhibitor (inflammation), 2. VEGF inhibitor (angiogenesis), 3. Notch-1 inhibitor (cancer), 4. IgE inhibitor (inflammation), 5. Small molecule tubulin polymerization inhibitor for hematologic cancer.

 

CellGentech, Inc.

http://www.cellgentech.com/

CellGentech is a biopharmaceutical company developing novel gene-based therapeutics, which use patent-protected technology incorporating cultured adipocytes for ex vivo gene therapy. The company's development pipeline includes novel gene therapy products for enzyme deficiency diseases and basal insulin supplementation for diabetes.

Anaeropharma Science Inc.
http://www.anaeropharma.co.jp/

Anaeropharma Science is a cancer drug development company based on the unique drug delivery technique using anaerobic bacteria such as the genus Bifidobacterium. The company is primarily focused on the tumor specific enzyme/pro-drug therapy by using the genetically engineered Bifidobacterium longum . APS001F is planned to enter phase I trials in early 2012. Anaeropharma Science was founded by three Professors of Medical School, Shinshu University.

Kinopharma Inc.
http://www.kinopharma.com/

KinoPharma is a biopharmaceutical company established in 2005 as a Tokyo Medical and Dentistry University spin-off and engaged in the discovery and development of small molecule drugs for novel Ser/Thr kinase targets based on the proprietary platform technologies. Pipeline includes kinase inhibitors for virus diseases and CNS disorders:
1. Anti-DNA Virus Program (broad spectrum over HSV, CMV, HPV, adv),
2. Anti-RNA Virus Program (broad spectrum over HCV, Dengue, Yellow Fever, Influenza),
3. CNS program (Down syndrome, Alzheimer's disease).
KinoPharma has been granted JST research funds for the virus and CNS programs.


NalaPro Technologies, Inc.
http://www.nalapro.com/

NalaPro Technologies is a bio-informatics development venture focused on the biotech/medical text-mining technique, founded by the team of two professors of Tokyo University and a spinout of one of the largest Japanese electronics companies. The company is developing the search engines with the precise machine dictionaries dedicated to the biotech/medical fields, that enables research/medical professionals to integrate necessary comprehensive text information of genomes, proteins, compounds and diseases from the public and commercial databases.